Principal Financial Group
AGIO icon

Principal Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Principal Financial Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,594
Closed -$327K – 2226
2024
Q2 		$327K Sell
7,594
-5,837
-43% -$211K ﹤0.01% 2043
2024
Q1 		$393K Sell
13,431
-1,228
-8% -$32.9K ﹤0.01% 2036
2023
Q4 		$326K Sell
14,659
-1,529
-9% -$34.3K ﹤0.01% 2039
2023
Q3 		$401K Buy
16,188
+2,609
+19% +$69K ﹤0.01% 1997
2023
Q2 		$385K Sell
13,579
-733
-5% -$18.2K ﹤0.01% 2011
2023
Q1 		$329K Buy
14,312
+2,400
+20% +$63.7K ﹤0.01% 2066
2022
Q4 		$334K Sell
11,912
-12,379
-51% -$349K ﹤0.01% 2075
2022
Q3 		$687K Sell
24,291
-18,624
-43% -$500K ﹤0.01% 1900
2022
Q2 		$951K Sell
42,915
-28,778
-40% -$650K ﹤0.01% 1925
2022
Q1 		$2.09M Sell
71,693
-29,126
-29% -$890K ﹤0.01% 1858
2021
Q4 		$3.31M Sell
100,819
-11,054
-10% -$445K ﹤0.01% 1778
2021
Q3 		$5.16M Sell
111,873
-4,670
-4% -$226K ﹤0.01% 1670
2021
Q2 		$6.42M Buy
116,543
+10,320
+10% +$577K ﹤0.01% 1629
2021
Q1 		$5.49M Buy
106,223
+14,222
+15% +$704K ﹤0.01% 1638
2020
Q4 		$3.99M Buy
92,001
+77,466
+533% +$3.06M ﹤0.01% 1645
2020
Q3 		$509K Sell
14,535
-5,785
-28% -$254K ﹤0.01% 2021
2020
Q2 		$1.09M Buy
20,320
+5,302
+35% +$246K ﹤0.01% 1817
2020
Q1 		$533K Buy
15,018
+1,565
+12% +$72.3K ﹤0.01% 1854
2019
Q4 		$643K Buy
13,453
+4,396
+49% +$166K ﹤0.01% 1901
2019
Q3 		$293K Sell
9,057
-4,395
-33% -$182K ﹤0.01% 2058
2019
Q2 		$671K Sell
13,452
-1,473
-10% -$78.7K ﹤0.01% 1906
2019
Q1 		$1.01M Buy
14,925
+1,194
+9% +$69.5K ﹤0.01% 1830
2018
Q4 		$633K Sell
13,731
-2,150
-14% -$133K ﹤0.01% 1875
2018
Q3 		$1.23M Buy
15,881
+633
+4% +$50.9K ﹤0.01% 1813
2018
Q2 		$1.28M Buy
15,248
+353
+2% +$30.8K ﹤0.01% 1810
2018
Q1 		$1.22M Buy
14,895
+1,533
+11% +$118K ﹤0.01% 1796
2017
Q4 		$764K Buy
13,362
+7,679
+135% +$483K ﹤0.01% 1890
2017
Q3 		$379K Sell
5,683
-1,400
-20% -$84.1K ﹤0.01% 1974
2017
Q2 		$364K Buy
7,083
+1,789
+34% +$91.5K ﹤0.01% 2011
2017
Q1 		$309K Sell
5,294
-351
-6% -$16.8K ﹤0.01% 2002
2016
Q4 		$236K Sell
5,645
-311
-5% -$16.3K ﹤0.01% 2066
2016
Q3 		$315K Hold
5,956
– – ﹤0.01% 1948
2016
Q2 		$250K Buy
+5,956
New +$294K ﹤0.01% 1977
2016
Q1 		– Sell
-4,635
Closed -$301K – 2175
2015
Q4 		$301K Sell
4,635
-33
-0.7% -$2.16K ﹤0.01% 1948
2015
Q3 		$330K Buy
+4,668
New +$456K ﹤0.01% 1930
2015
Q2 		– Sell
-2,713
Closed -$256K – 2173
2015
Q1 		$256K Buy
2,713
+531
+24% +$59.5K ﹤0.01% 1967
2014
Q4 		$244K Sell
2,182
-2,341
-52% -$209K ﹤0.01% 1987
2014
Q3 		$277K Buy
+4,523
New +$195K ﹤0.01% 1948
2014
Q2 		– Sell
-41,000
Closed -$1.6M – 2241
2014
Q1 		$1.6M Buy
41,000
+400
+1% +$13.4K ﹤0.01% 1703
2013
Q4 		$972K Buy
40,600
+600
+2% +$13.7K ﹤0.01% 1782
2013
Q3 		$1.12M Buy
+40,000
New +$1.1M ﹤0.01% 1730

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Principal Financial Group's AGIO Position: Q3 2024 in Review

Principal Financial Group sold out of Agios Pharmaceuticals (AGIO) in Q3 2024, closing a stake of 7,594 shares — an estimated $327K sold.

Principal Financial Group first reported a position in AGIO in Q3 2013 and held it in 41 quarters. The position peaked at $6.42M in Q2 2021. 207 funds tracked by Wall St. Rank hold AGIO as of Q3 2024.

  • Principal Financial Group reported no remaining Agios Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 7,594 Agios Pharmaceuticals shares in Q3 2024, an estimated $327K.
  • Principal Financial Group first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 41 quarters.
  • Principal Financial Group's Agios Pharmaceuticals position peaked at $6.42M in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.